BGM0504
A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes
BrightGene Bio-Medical Technology Co · Phase 2 · Recruiting · Enrollment 200
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.